Stamford, United States
OncoSynergy, founded in 2011, is a promising biotechnology startup with a compelling vision: "Cancer treatment in one dose." Emerging from UCSF and the JLABS South San Francisco incubator, this Stamford, Connecticut-based company is focused on redefining cancer treatment, particularly for devastating conditions like glioblastoma.
With a small and agile team, OncoSynergy launched its first clinical trial in 2020, targeting aggressive brain cancer. Their ambitious approach aims to maximize patient survival while maintaining quality of life with minimal side effects, reflecting their slogan, "Physician-founded, patient-focused."
The company secured a $3.25M Early VC investment on 01 September 2020 and continues to be at the forefront of innovative cancer research. Investors should note its strategic position near New York City, diverse expertise, and commitment to tackling aggressive cancers, making it a promising candidate for further investment.
